PG2152-PJT6527-COL112333-ET3-Gibco-Protein-Expression-Basics-Global-F

Gibco Protein Expression Basics is an online hub that brings together educational content and tools to enhance your research. Here you can access our protein expression selection guide, handbook, educational videos, and technical resources. Start here if you are new to protein expression or need to refresh your knowledge.

Do you need guidance on a new project, troubleshooting expertise, or more information on a product?

Share your protein expression application needs with us, and one of our protein expression specialists will contact you to discuss the solutions we can provide.

Contact a specialist

Gibco protein expression webinars

Watch on-demand webinars with leading industry experts and see the latest advances in protein expression.

Video Player is loading.
Current Time 0:00
Duration 1:11:13
Loaded: 0.23%
Stream Type LIVE
Remaining Time 1:11:13
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    COVID-19 Serology Assays and Cell Therapy Strategies

    Presented by Fatima Amanat (Department of Microbiology, Icahn School of Medicine at Mount Sinai), Dean Lee (Director of the Cellular Therapy and Cancer Immunology Program and Physician at Nationwide Children's Hospital), and Lior Raviv (Vice President Development & Operations, Pluristem Therapeutics Inc.)

    Video Player is loading.
    Current Time 0:00
    Duration 20:14
    Loaded: 0.81%
    Stream Type LIVE
    Remaining Time 20:14
     
    1x
      • Chapters
      • descriptions off, selected
      • captions off, selected
      • en (Main), selected

      Harnessing the Power of Protein Expression Systems in Vaccine Development

      Presented by Roland Leathers, PhD, Senior Manager, Strategic Alliances Europe, India & Australasia, Stem Cell Systems & Drug Discovery Solutions, Thermo Fisher Scientific

      Video Player is loading.
      Current Time 0:00
      Duration 26:50
      Loaded: 0.61%
      Stream Type LIVE
      Remaining Time 26:50
       
      1x
        • Chapters
        • descriptions off, selected
        • captions off, selected
        • en (Main), selected

        Streamlining the Biologics Development Process: From Transient to Stable Production in the ExpiCHO System

        Presented by Jonathan Zmuda, Ph.D.
        Video Player is loading.
        Current Time 0:00
        Duration 25:33
        Loaded: 0.64%
        Stream Type LIVE
        Remaining Time 25:33
         
        1x
          • Chapters
          • descriptions off, selected
          • captions off, selected
          • en (Main), selected

          ExpiSf Expression System: A Chemically defined baculovirus-based expression system for enhanced protein and virus production in Sf9 cells
          Presented by Ken Thompson, PhD

          Video Player is loading.
          Current Time 0:00
          Duration 19:43
          Loaded: 0.83%
          Stream Type LIVE
          Remaining Time 19:43
           
          1x
            • Chapters
            • descriptions off, selected
            • captions off, selected
            • en (Main), selected

            Expression, purification, and characterization of difficult to express membrane proteins in the Expi293 and ExpiCHO expression systems
            Presented by Anass Jawhari, PhD, Chief Scientific Officer, CALIXAR

            Video Player is loading.
            Current Time 0:00
            Duration 15:19
            Loaded: 1.07%
            Stream Type LIVE
            Remaining Time 15:19
             
            1x
              • Chapters
              • descriptions off, selected
              • captions off, selected
              • en (Main), selected

              Enabling next-generation targeted siRNA therapies with ExpiCHO
              Presented by Ian Huggins, PhD, Post-Doctoral Fellow, UC San Diego

              Video Player is loading.
              Current Time 0:00
              Duration 21:31
              Loaded: 0.78%
              Stream Type LIVE
              Remaining Time 21:31
               
              1x
                • Chapters
                • descriptions off, selected
                • captions off, selected
                • en (Main), selected

                Factor V expression in ExpiCHO cells
                Presented by Laurent Mosnier, PhD, Associate Professor, The Scripps Research Institute

                Video Player is loading.
                Current Time 0:00
                Duration 32:20
                Loaded: 0.51%
                Stream Type LIVE
                Remaining Time 32:20
                 
                1x
                  • Chapters
                  • descriptions off, selected
                  • captions off, selected
                  • en (Main), selected

                  Expi293: new tools for structural biology and difficult to express proteins
                  Presented by Jon Zmuda, PhD, Director Cell Biology R&D, Thermo Fisher Scientific

                  Gibco ExpressionWorld 2016: Development of a mammalian recombinant protein production suite

                  Gibco ExpressionWorld 2016: Streamlining the drug development process with the ExpiCHO system

                  Protein Expression Publication Hub

                  Protein expression systems enable high-yield, consistent protein production for a diverse array of downstream applications. Protein solubility, functionality, purification speed, and yield are crucial factors to consider when choosing an expression system. Thermo Fisher Scientific drives innovation in the protein expression space, accelerating the development of new platforms that offer integrated solutions to accommodate your research needs.

                  This publication hub offers an in-depth look into how scientists like you advance their research with Expi protein expression systems. Our systems are optimized to harness the power of transient expression with the goal of delivering high-yield, consistent proteins for biotechnology, gene therapy, immunotherapy, immunology, structural, functional, vaccine, and infectious disease research.

                  Search the publication hub by filtering based on application, host type or expression system, or by entering a search term below.

                  1. Applications:

                  1. Host type:

                  2. Expression system:

                  TitleJournalYearApplicationExpression System
                  SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainThe Journal of Immunology2021COVIDExpi293
                  Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapyScientific Reports2021ImmunotherapyExpi293
                  Isolation and characterization of porcine monoclonal antibodies revealed two distinct serotype-independent epitopes on VP2 of foot-and-mouth disease virusJournal of General Virology2021Infectious DiseaseExpiCHO
                  Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell ImmunotherapyMolecular Diagnosis & Therapy2021ImmunotherapyExpi293
                  Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodiesPLoS One2021ImmunologyExpiCHO
                  Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionCommunications Biology2021Protein Structure/FunctionExpiCHO
                  Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display librariesCell Discovery2021COVIDExpi293
                  Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognitionMolecular Cell2021Protein Structure/FunctionExpi293
                  Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic AnalysisACS Omega2020COVIDExpi293 and ExpiCHO
                  Production of SARS-CoV-2 virus-like particles in insect cellsMDPI Vaccines2021COVIDExpiSf
                  Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2dVaccine2021VaccineExpiSf
                  Enhancement of antibody-dependent cellular cytotoxicity and phagocytosis in anti‐HIV‐1 bovine chimeric broadly-neutralizing antibodiesJournal of Virology2021Infectious Diseases Expi293
                  Proprotein Convertase Is the Highest-Level Activator of the Alternative Complement Pathway in the BloodThe Journal of Immunology2021Protein Structure/FunctionExpiCHO
                  Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particlesScientific Reports2021BiotechnologyExpi293
                  Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapyNature2021ImmunotherapyExpi293
                  Structures of Foot-and-mouth Disease Virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralizationPLOS Pathogens2021Virus Structure/FunctionExpiCHO
                  Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteinsNature Structural & Molecular Biology2021Infectious Diseases ExpiCHO
                  Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactionsMolecular Biology Reports2020Protein Structure/FunctionExpiSf
                  Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infectionCell Reports2021Infectious Diseases Expi293 and ExpiCHO
                  Antibody evasion by the P.1 strain of SARS-CoV-2Cell2021COVIDExpi293 and ExpiCHO
                  Long-term persistence of RBD + memory B cells encoding neutralizing antibodies in SARS-CoV-2 infectionCell Reports Medicine2021COVIDExpi293
                  Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaquesNature Communications2021COVIDExpi293
                  Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit VaccinationThe Journal of Immunology2021COVIDExpi293
                  Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survivalNature Communications2021COVIDExpi293
                  Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disordersPNAS2021Protein Structure/FunctionExpi293
                  Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteinsScientific Reports2021COVIDExpi293
                  Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patientsEmerging Microbes & Infections2021COVIDExpi293
                  A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cellsScientific Reports2021Immunology ExpiCHO
                  Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune diseaseJournal of Autoimmunity2021Immunology Expi293
                  Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30Cancer Immunology, Immunotherapy2021ImmunotherapyExpi293
                  Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic feverCell2021Infectious Diseases ExpiCHO
                  Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseJournal for ImmunoTherapy of Cancer2021ImmunotherapyExpiCHO
                  Performance of a SARS CoV-2 antibody ELISA based on simultaneous measurement of antibodies against the viral nucleoprotein and receptor-binding domainEuropean Journal of Clinical Microbiology & Infectious Diseases2021COVIDExpi293
                  A novel multiplexed Enzyme-Linked Immunosorbent Assay for the detection of IgG seroreactivity to cytomegalovirus (CMV) UL144Journal of Clinical Microbiology2021BiotechnologyExpi293
                  Polymorphic SERPINA3-R124C reduces pathogenesis of its wild type by shortening the life time of oligomeric AβBioscience, Biotechnology, and Biochemistry2021Protein Structure/FunctionExpi293
                  Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19Scientific Reports2020COVIDExpiCHO
                  Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variantsNature2021COVIDExpi293 and ExpiCHO
                  Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersNature Communications2021COVIDExpi293
                  Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNature Nanotechnology2021BiotechnologyExpi293
                  Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody ResponsesACS Nano2021COVIDExpi293
                  Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancerJournal for ImmunoTherapy of Cancer2021ImmunotherapyExpiCHO
                  High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identificationNucleic Acids Research2021Infectious Diseases ExpiCHO
                  A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral DrugsThe Journal of Immunology2021COVIDExpi293
                  Structural mechanism of laminin recognition by integrinNature Communications2021Protein Structure/FunctionExpi293
                  Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsScience2021COVIDExpi293
                  Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28–Stimulated T Cell IFN-γ and TNF-α ProductionThe Journal of Immunology2021Immunology Expi293
                  Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockadeJournal for ImmunoTherapy of Cancer2021ImmunotherapyExpiCHO
                  Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA libraryNucleic Acids Research2021COVIDExpi293
                  Broadly cross-reactive human antibodies that inhibit genogroup I and II norovirusesNature Communications2021Infectious Diseases ExpiCHO
                  Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assayJCI Insight2021COVIDExpi293
                  CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challengeScientific Reports2021COVIDExpiCHO
                  Site-Specific Bioconjugation Using SMARTag® Technology: A Practical and Effective Chemoenzymatic Approach to Generate Antibody–Drug ConjugatesMethods in Molecular Biology2019BiotechnologyExpiCHO
                  Optimizing high throughput antibody purification by using continuous chromatography mediaProtein Expression and Purification 2019BiotechnologyExpi293 and ExpiCHO
                  Simply Mixing Poly Protein G with Detection Antibodies Enhances the Detection Limit and Sensitivity of ImmunoassaysAnalytical Chemistry2019BiotechnologyExpi293
                  Site Selective Antibody-Oligonucleotide Conjugation via Microbial TransglutaminaseMolecules2019BiotechnologyExpiCHO
                  Rapid isolation and enrichment of extracellular vesicle preparations using anion exchange chromatographyNature Scientific Reports2018BiotechnologyExpi293
                  Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteinsBiotechnology Progress2018BiotechnologyExpi293 and ExpiCHO
                  Scalable method utilizing low pH for DNA removal in the harvest of recombinant adeno-associated virus vectorsJournal of Chromatography B2019Gene Therapy Expi293
                  Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus SystemHuman Gene Therapy Methods2017Gene Therapy Expi293
                  Chemically Defined, High-Density Insect Cell-Based Expression System for Scalable AAV Vector ProductionMolecular Therapy Methods and Clinical Development2020Gene Therapy ExpiSf
                  Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct VectorsMolecular Therapy Methods and Clinical Development2020Gene Therapy Expi293
                  Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer’s diseasePLoS One2019ImmunotherapyExpi293
                  Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challengePLoS Pathogens 2018ImmunotherapyExpi293
                  Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog PodoplaninMonoclonal Antibodies in Immunodiagnosis and Immunotherapy2018ImmunotherapyExpiCHO
                  Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk regionEMBO Molecular Medicine 2020ImmunotherapyExpiCHO
                  Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52Frontiers in Immunology2019ImmunotherapyExpi293
                  Design and preclinical characterization of ALXN1210: a novel anti-C5 antibody with extended duration of actionPLOS One 2018ImmunotherapyExpi293
                  Antibody–Drug Conjugates Using Mouse–Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft ModelMonoclonal Antibodies in Immunodiagnosis and Immunotherapy2020ImmunotherapyExpiCHO
                  Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer GrowthBiomolecules2019ImmunotherapyExpi293
                  Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer PatientsClinical Cancer Research2019ImmunotherapyExpiCHO
                  Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunityClinical and Translational Immunology2019ImmunotherapyExpi293 and ExpiCHO
                  The Strong Propensity of Cadherin‐23 for Aggregation Inhibits Cell MigrationMolecular Oncology2019ImmunotherapyExpiCHO
                  Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncologyJournal of Allergy and Clinical Immunology2018ImmunotherapyExpi293
                  Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicityJournal of Clinical Investigation2020ImmunotherapyExpi293 and ExpiCHO
                  Enhanced Production of Anti-PD1 Antibody in CHO Cells through Transient Co-Transfection with Anti-Apoptotic Gene Bcl-xL Combined with RapamycinBioprocess and Biosystems Engineering2018ImmunotherapyExpiCHO
                  Discovery and characterization of single-domain antibodies for polymeric Ig receptor-mediated mucosal delivery of biologicsmAbs2020ImmunologyExpi293 and ExpiCHO
                  Engineering a high-affinity peptide binding site into the anti-CEA mAb M5AProtein Engineering Design & Selection2017ImmunologyExpiCHO
                  Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptorsImmunology Letters 2018ImmunologyExpi293
                  Early identification of unusually clustered mutations and root causes in therapeutic antibody developmentBiotechnology and Bioengineering 2018ImmunologyExpiCHO
                  Stabilization of the CD81 Large Extracellular Loop with De Novo Disulfide Bonds Improves Its Amenability for Peptide GraftingMDPI Pharmaceutics2018ImmunologyExpiCHO
                  Rapid charge variant analysis of monoclonal antibodies to support lead candidate biopharmaceutical developmentJournal of Chromatography B2018ImmunologyExpi293 and ExpiCHO
                  Lysosomal Protein Thermal Stability Does Not Correlate With Cellular Half-Life: Global Observations and a Case Study of Tripeptidyl-Peptidase 1Biochemical Journal 2020Protein Structure/FunctionExpiCHO
                  Molecular basis for dyneinopathies reveals insight into dynein regulation and dysfunctioneLife Science2019Protein Structure/FunctionExpiSf
                  Comparative Glycopeptide Analysis for Protein Glycosylation by Liquid Chromatography and Tandem Mass Spectrometry: Variation in Glycosylation Patterns of Site-Directed Mutagenized GlycoproteinInternational Journal of Analytical Chemistry 2018Protein Structure/FunctionExpiCHO
                  Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinasesNature Scientific Reports2019Protein Structure/FunctionExpiCHO
                  Tailored tetravalent antibodies potently and specifically activate Wnt/Frizzled pathways in cells, organoids and miceeLife Science2019Protein Structure/FunctionExpi293
                  IL-2 Shapes the Survival and Plasticity of IL-17–Producing γδ T CellsJournal of Immunology2017Protein Structure/FunctionExpi293
                  Identification of the gene that codes for the σ2 receptorPNAS2017Protein Structure/FunctionExpi293
                  Novel CH1:CL interfaces that enhance correct light chain pairing in heterodimeric bispecific antibodies Protein Engineering, Design and Selection2017Protein Structure/FunctionExpi293 and ExpiCHO
                  Mechanically interlocked functionalization of monoclonal antibodiesNature Communications2018Protein Structure/FunctionExpiCHO
                  Antibody-drug conjugate library prepared by scanning insertion of the aldehyde tag into IgG1 constant regionsmAbs2018Protein Structure/FunctionExpiCHO
                  Pac1/LIS1 promotes an uninhibited conformation of dynein that coordinates its localization and activityNature Cell Biology2020Protein Structure/FunctionExpiSf
                  The Biochemical and Functional Characterization of M28 Aminopeptidase Protein Secreted by Acanthamoeba spp. on Host Cell InteractionMolecules2019Protein Structure/FunctionExpiCHO
                  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyNature2020COVIDExpiCHO
                  Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteinsMolecular Human Reproduction2018Protein Structure/FunctionExpi293 and ExpiCHO
                  Expression of glycosylated human prolactin in HEK293 cells and related N-glycan composition analysisAMB Express2019Protein Structure/FunctionExpi293
                  Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assaysProtein Expression and Purification 2020COVIDExpi293
                  Oligomeric state of the ZIKV E protein defines protective immune responsesNature Communications2019VaccineExpi293
                  In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-DimersNature Scientific Reports2017VaccineExpi293
                  HIV-1 vaccine design through minimizing envelope metastabilityScience Advances 2018Vaccine ExpiCHO
                  Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in MiceFrontiers in Microbiology2019Vaccine Expi293
                  Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotypePLOS Neglected Tropical Diseases 2018Vaccine Expi293
                  Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-IgEBioMedicine 2018Vaccine Expi293
                  Neuraminidase Inhibition Contributes to Influenza A Virus Neutralization by Anti-Hemagglutinin Stem AntibodiesJournal of Experimental Medicine 2019Vaccine Expi293
                  Zika virus-like particle (VLP) based vaccinePLOS Neglected Tropical Diseases 2017Vaccine Expi293
                  Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization ActivityJournal of Pharmaceutical Sciences2019Vaccine ExpiCHO
                  Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig GeneCell Host & Microbe 2018Vaccine ExpiCHO
                  Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomicseLife Science2019Vaccine Expi293 and ExpiCHO
                  Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitroAntiviral Research2020COVIDExpiCHO
                  Development of an inactivated vaccine candidate for SARS-CoV-2Science2020COVIDExpi293
                  Optimization of Surface Display of DENV2 E Protein on a Nanoparticle to Induce Virus Specific Neutralizing Antibody ResponsesBioconjugate Chemistry2018Vaccine Expi293
                  Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccinesScience Advances 2020Vaccine ExpiCHO
                  Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational IncompatibilityCell Host & Microbe 2019Vaccine ExpiCHO
                  Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBAActa Crystallographica Section F Structural Biology Communications2017Vaccine Expi293
                  SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test SetupCurrent Protocols in Microbiology2020COVIDExpi293
                  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience2020COVIDExpi293
                  A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoVScience2020COVIDExpi293 and ExpiCHO
                  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenPNAS2017COVIDExpi293
                  Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid AntibodiesCell2020COVIDExpiCHO
                  Cryo-EM structure of full-length HIV-1 Env bound with the Fab of antibody PG16Journal of Molecular Biology2020COVIDExpi293
                  Structure-based design of prefusion-stabilized SARS-CoV-2 spikesScience2020COVIDExpiCHO
                  Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spikeNature 2020COVIDExpi293

                  Expi Expression Systems

                  Application notes

                  Protocol Calculator

                  Literature

                  Protocol guide

                  Scientific posters

                  Additional resources

                  Gibco protein expression webinars

                  Watch on-demand webinars with leading industry experts and see the latest advances in protein expression.

                  Video Player is loading.
                  Current Time 0:00
                  Duration 1:11:13
                  Loaded: 0.23%
                  Stream Type LIVE
                  Remaining Time 1:11:13
                   
                  1x
                    • Chapters
                    • descriptions off, selected
                    • captions off, selected
                    • en (Main), selected

                    COVID-19 Serology Assays and Cell Therapy Strategies

                    Presented by Fatima Amanat (Department of Microbiology, Icahn School of Medicine at Mount Sinai), Dean Lee (Director of the Cellular Therapy and Cancer Immunology Program and Physician at Nationwide Children's Hospital), and Lior Raviv (Vice President Development & Operations, Pluristem Therapeutics Inc.)

                    Video Player is loading.
                    Current Time 0:00
                    Duration 20:14
                    Loaded: 0.81%
                    Stream Type LIVE
                    Remaining Time 20:14
                     
                    1x
                      • Chapters
                      • descriptions off, selected
                      • captions off, selected
                      • en (Main), selected

                      Harnessing the Power of Protein Expression Systems in Vaccine Development

                      Presented by Roland Leathers, PhD, Senior Manager, Strategic Alliances Europe, India & Australasia, Stem Cell Systems & Drug Discovery Solutions, Thermo Fisher Scientific

                      Video Player is loading.
                      Current Time 0:00
                      Duration 26:50
                      Loaded: 0.61%
                      Stream Type LIVE
                      Remaining Time 26:50
                       
                      1x
                        • Chapters
                        • descriptions off, selected
                        • captions off, selected
                        • en (Main), selected

                        Streamlining the Biologics Development Process: From Transient to Stable Production in the ExpiCHO System

                        Presented by Jonathan Zmuda, Ph.D.
                        Video Player is loading.
                        Current Time 0:00
                        Duration 25:33
                        Loaded: 0.64%
                        Stream Type LIVE
                        Remaining Time 25:33
                         
                        1x
                          • Chapters
                          • descriptions off, selected
                          • captions off, selected
                          • en (Main), selected

                          ExpiSf Expression System: A Chemically defined baculovirus-based expression system for enhanced protein and virus production in Sf9 cells
                          Presented by Ken Thompson, PhD

                          Video Player is loading.
                          Current Time 0:00
                          Duration 19:43
                          Loaded: 0.85%
                          Stream Type LIVE
                          Remaining Time 19:43
                           
                          1x
                            • Chapters
                            • descriptions off, selected
                            • captions off, selected
                            • en (Main), selected

                            Expression, purification, and characterization of difficult to express membrane proteins in the Expi293 and ExpiCHO expression systems
                            Presented by Anass Jawhari, PhD, Chief Scientific Officer, CALIXAR

                            Video Player is loading.
                            Current Time 0:00
                            Duration 15:19
                            Loaded: 1.09%
                            Stream Type LIVE
                            Remaining Time 15:19
                             
                            1x
                              • Chapters
                              • descriptions off, selected
                              • captions off, selected
                              • en (Main), selected

                              Enabling next-generation targeted siRNA therapies with ExpiCHO
                              Presented by Ian Huggins, PhD, Post-Doctoral Fellow, UC San Diego

                              Video Player is loading.
                              Current Time 0:00
                              Duration 21:31
                              Loaded: 0.78%
                              Stream Type LIVE
                              Remaining Time 21:31
                               
                              1x
                                • Chapters
                                • descriptions off, selected
                                • captions off, selected
                                • en (Main), selected

                                Factor V expression in ExpiCHO cells
                                Presented by Laurent Mosnier, PhD, Associate Professor, The Scripps Research Institute

                                Video Player is loading.
                                Current Time 0:00
                                Duration 32:20
                                Loaded: 0.52%
                                Stream Type LIVE
                                Remaining Time 32:20
                                 
                                1x
                                  • Chapters
                                  • descriptions off, selected
                                  • captions off, selected
                                  • en (Main), selected

                                  Expi293: new tools for structural biology and difficult to express proteins
                                  Presented by Jon Zmuda, PhD, Director Cell Biology R&D, Thermo Fisher Scientific

                                  Gibco ExpressionWorld 2016: Development of a mammalian recombinant protein production suite

                                  Gibco ExpressionWorld 2016: Streamlining the drug development process with the ExpiCHO system

                                  Protein Expression Publication Hub

                                  Protein expression systems enable high-yield, consistent protein production for a diverse array of downstream applications. Protein solubility, functionality, purification speed, and yield are crucial factors to consider when choosing an expression system. Thermo Fisher Scientific drives innovation in the protein expression space, accelerating the development of new platforms that offer integrated solutions to accommodate your research needs.

                                  This publication hub offers an in-depth look into how scientists like you advance their research with Expi protein expression systems. Our systems are optimized to harness the power of transient expression with the goal of delivering high-yield, consistent proteins for biotechnology, gene therapy, immunotherapy, immunology, structural, functional, vaccine, and infectious disease research.

                                  Search the publication hub by filtering based on application, host type or expression system, or by entering a search term below.

                                  1. Applications:

                                  1. Host type:

                                  2. Expression system:

                                  TitleJournalYearApplicationExpression System
                                  SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainThe Journal of Immunology2021COVIDExpi293
                                  Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapyScientific Reports2021ImmunotherapyExpi293
                                  Isolation and characterization of porcine monoclonal antibodies revealed two distinct serotype-independent epitopes on VP2 of foot-and-mouth disease virusJournal of General Virology2021Infectious DiseaseExpiCHO
                                  Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell ImmunotherapyMolecular Diagnosis & Therapy2021ImmunotherapyExpi293
                                  Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodiesPLoS One2021ImmunologyExpiCHO
                                  Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionCommunications Biology2021Protein Structure/FunctionExpiCHO
                                  Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display librariesCell Discovery2021COVIDExpi293
                                  Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognitionMolecular Cell2021Protein Structure/FunctionExpi293
                                  Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic AnalysisACS Omega2020COVIDExpi293 and ExpiCHO
                                  Production of SARS-CoV-2 virus-like particles in insect cellsMDPI Vaccines2021COVIDExpiSf
                                  Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2dVaccine2021VaccineExpiSf
                                  Enhancement of antibody-dependent cellular cytotoxicity and phagocytosis in anti‐HIV‐1 bovine chimeric broadly-neutralizing antibodiesJournal of Virology2021Infectious Diseases Expi293
                                  Proprotein Convertase Is the Highest-Level Activator of the Alternative Complement Pathway in the BloodThe Journal of Immunology2021Protein Structure/FunctionExpiCHO
                                  Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particlesScientific Reports2021BiotechnologyExpi293
                                  Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapyNature2021ImmunotherapyExpi293
                                  Structures of Foot-and-mouth Disease Virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralizationPLOS Pathogens2021Virus Structure/FunctionExpiCHO
                                  Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteinsNature Structural & Molecular Biology2021Infectious Diseases ExpiCHO
                                  Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactionsMolecular Biology Reports2020Protein Structure/FunctionExpiSf
                                  Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infectionCell Reports2021Infectious Diseases Expi293 and ExpiCHO
                                  Antibody evasion by the P.1 strain of SARS-CoV-2Cell2021COVIDExpi293 and ExpiCHO
                                  Long-term persistence of RBD + memory B cells encoding neutralizing antibodies in SARS-CoV-2 infectionCell Reports Medicine2021COVIDExpi293
                                  Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaquesNature Communications2021COVIDExpi293
                                  Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit VaccinationThe Journal of Immunology2021COVIDExpi293
                                  Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survivalNature Communications2021COVIDExpi293
                                  Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disordersPNAS2021Protein Structure/FunctionExpi293
                                  Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteinsScientific Reports2021COVIDExpi293
                                  Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patientsEmerging Microbes & Infections2021COVIDExpi293
                                  A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cellsScientific Reports2021Immunology ExpiCHO
                                  Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune diseaseJournal of Autoimmunity2021Immunology Expi293
                                  Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30Cancer Immunology, Immunotherapy2021ImmunotherapyExpi293
                                  Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic feverCell2021Infectious Diseases ExpiCHO
                                  Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseJournal for ImmunoTherapy of Cancer2021ImmunotherapyExpiCHO
                                  Performance of a SARS CoV-2 antibody ELISA based on simultaneous measurement of antibodies against the viral nucleoprotein and receptor-binding domainEuropean Journal of Clinical Microbiology & Infectious Diseases2021COVIDExpi293
                                  A novel multiplexed Enzyme-Linked Immunosorbent Assay for the detection of IgG seroreactivity to cytomegalovirus (CMV) UL144Journal of Clinical Microbiology2021BiotechnologyExpi293
                                  Polymorphic SERPINA3-R124C reduces pathogenesis of its wild type by shortening the life time of oligomeric AβBioscience, Biotechnology, and Biochemistry2021Protein Structure/FunctionExpi293
                                  Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19Scientific Reports2020COVIDExpiCHO
                                  Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variantsNature2021COVIDExpi293 and ExpiCHO
                                  Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersNature Communications2021COVIDExpi293
                                  Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNature Nanotechnology2021BiotechnologyExpi293
                                  Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody ResponsesACS Nano2021COVIDExpi293
                                  Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancerJournal for ImmunoTherapy of Cancer2021ImmunotherapyExpiCHO
                                  High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identificationNucleic Acids Research2021Infectious Diseases ExpiCHO
                                  A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral DrugsThe Journal of Immunology2021COVIDExpi293
                                  Structural mechanism of laminin recognition by integrinNature Communications2021Protein Structure/FunctionExpi293
                                  Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsScience2021COVIDExpi293
                                  Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28–Stimulated T Cell IFN-γ and TNF-α ProductionThe Journal of Immunology2021Immunology Expi293
                                  Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockadeJournal for ImmunoTherapy of Cancer2021ImmunotherapyExpiCHO
                                  Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA libraryNucleic Acids Research2021COVIDExpi293
                                  Broadly cross-reactive human antibodies that inhibit genogroup I and II norovirusesNature Communications2021Infectious Diseases ExpiCHO
                                  Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assayJCI Insight2021COVIDExpi293
                                  CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challengeScientific Reports2021COVIDExpiCHO
                                  Site-Specific Bioconjugation Using SMARTag® Technology: A Practical and Effective Chemoenzymatic Approach to Generate Antibody–Drug ConjugatesMethods in Molecular Biology2019BiotechnologyExpiCHO
                                  Optimizing high throughput antibody purification by using continuous chromatography mediaProtein Expression and Purification 2019BiotechnologyExpi293 and ExpiCHO
                                  Simply Mixing Poly Protein G with Detection Antibodies Enhances the Detection Limit and Sensitivity of ImmunoassaysAnalytical Chemistry2019BiotechnologyExpi293
                                  Site Selective Antibody-Oligonucleotide Conjugation via Microbial TransglutaminaseMolecules2019BiotechnologyExpiCHO
                                  Rapid isolation and enrichment of extracellular vesicle preparations using anion exchange chromatographyNature Scientific Reports2018BiotechnologyExpi293
                                  Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteinsBiotechnology Progress2018BiotechnologyExpi293 and ExpiCHO
                                  Scalable method utilizing low pH for DNA removal in the harvest of recombinant adeno-associated virus vectorsJournal of Chromatography B2019Gene Therapy Expi293
                                  Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus SystemHuman Gene Therapy Methods2017Gene Therapy Expi293
                                  Chemically Defined, High-Density Insect Cell-Based Expression System for Scalable AAV Vector ProductionMolecular Therapy Methods and Clinical Development2020Gene Therapy ExpiSf
                                  Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct VectorsMolecular Therapy Methods and Clinical Development2020Gene Therapy Expi293
                                  Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer’s diseasePLoS One2019ImmunotherapyExpi293
                                  Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challengePLoS Pathogens 2018ImmunotherapyExpi293
                                  Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog PodoplaninMonoclonal Antibodies in Immunodiagnosis and Immunotherapy2018ImmunotherapyExpiCHO
                                  Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk regionEMBO Molecular Medicine 2020ImmunotherapyExpiCHO
                                  Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52Frontiers in Immunology2019ImmunotherapyExpi293
                                  Design and preclinical characterization of ALXN1210: a novel anti-C5 antibody with extended duration of actionPLOS One 2018ImmunotherapyExpi293
                                  Antibody–Drug Conjugates Using Mouse–Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft ModelMonoclonal Antibodies in Immunodiagnosis and Immunotherapy2020ImmunotherapyExpiCHO
                                  Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer GrowthBiomolecules2019ImmunotherapyExpi293
                                  Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer PatientsClinical Cancer Research2019ImmunotherapyExpiCHO
                                  Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunityClinical and Translational Immunology2019ImmunotherapyExpi293 and ExpiCHO
                                  The Strong Propensity of Cadherin‐23 for Aggregation Inhibits Cell MigrationMolecular Oncology2019ImmunotherapyExpiCHO
                                  Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncologyJournal of Allergy and Clinical Immunology2018ImmunotherapyExpi293
                                  Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicityJournal of Clinical Investigation2020ImmunotherapyExpi293 and ExpiCHO
                                  Enhanced Production of Anti-PD1 Antibody in CHO Cells through Transient Co-Transfection with Anti-Apoptotic Gene Bcl-xL Combined with RapamycinBioprocess and Biosystems Engineering2018ImmunotherapyExpiCHO
                                  Discovery and characterization of single-domain antibodies for polymeric Ig receptor-mediated mucosal delivery of biologicsmAbs2020ImmunologyExpi293 and ExpiCHO
                                  Engineering a high-affinity peptide binding site into the anti-CEA mAb M5AProtein Engineering Design & Selection2017ImmunologyExpiCHO
                                  Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptorsImmunology Letters 2018ImmunologyExpi293
                                  Early identification of unusually clustered mutations and root causes in therapeutic antibody developmentBiotechnology and Bioengineering 2018ImmunologyExpiCHO
                                  Stabilization of the CD81 Large Extracellular Loop with De Novo Disulfide Bonds Improves Its Amenability for Peptide GraftingMDPI Pharmaceutics2018ImmunologyExpiCHO
                                  Rapid charge variant analysis of monoclonal antibodies to support lead candidate biopharmaceutical developmentJournal of Chromatography B2018ImmunologyExpi293 and ExpiCHO
                                  Lysosomal Protein Thermal Stability Does Not Correlate With Cellular Half-Life: Global Observations and a Case Study of Tripeptidyl-Peptidase 1Biochemical Journal 2020Protein Structure/FunctionExpiCHO
                                  Molecular basis for dyneinopathies reveals insight into dynein regulation and dysfunctioneLife Science2019Protein Structure/FunctionExpiSf
                                  Comparative Glycopeptide Analysis for Protein Glycosylation by Liquid Chromatography and Tandem Mass Spectrometry: Variation in Glycosylation Patterns of Site-Directed Mutagenized GlycoproteinInternational Journal of Analytical Chemistry 2018Protein Structure/FunctionExpiCHO
                                  Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinasesNature Scientific Reports2019Protein Structure/FunctionExpiCHO
                                  Tailored tetravalent antibodies potently and specifically activate Wnt/Frizzled pathways in cells, organoids and miceeLife Science2019Protein Structure/FunctionExpi293
                                  IL-2 Shapes the Survival and Plasticity of IL-17–Producing γδ T CellsJournal of Immunology2017Protein Structure/FunctionExpi293
                                  Identification of the gene that codes for the σ2 receptorPNAS2017Protein Structure/FunctionExpi293
                                  Novel CH1:CL interfaces that enhance correct light chain pairing in heterodimeric bispecific antibodies Protein Engineering, Design and Selection2017Protein Structure/FunctionExpi293 and ExpiCHO
                                  Mechanically interlocked functionalization of monoclonal antibodiesNature Communications2018Protein Structure/FunctionExpiCHO
                                  Antibody-drug conjugate library prepared by scanning insertion of the aldehyde tag into IgG1 constant regionsmAbs2018Protein Structure/FunctionExpiCHO
                                  Pac1/LIS1 promotes an uninhibited conformation of dynein that coordinates its localization and activityNature Cell Biology2020Protein Structure/FunctionExpiSf
                                  The Biochemical and Functional Characterization of M28 Aminopeptidase Protein Secreted by Acanthamoeba spp. on Host Cell InteractionMolecules2019Protein Structure/FunctionExpiCHO
                                  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyNature2020COVIDExpiCHO
                                  Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteinsMolecular Human Reproduction2018Protein Structure/FunctionExpi293 and ExpiCHO
                                  Expression of glycosylated human prolactin in HEK293 cells and related N-glycan composition analysisAMB Express2019Protein Structure/FunctionExpi293
                                  Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assaysProtein Expression and Purification 2020COVIDExpi293
                                  Oligomeric state of the ZIKV E protein defines protective immune responsesNature Communications2019VaccineExpi293
                                  In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-DimersNature Scientific Reports2017VaccineExpi293
                                  HIV-1 vaccine design through minimizing envelope metastabilityScience Advances 2018Vaccine ExpiCHO
                                  Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in MiceFrontiers in Microbiology2019Vaccine Expi293
                                  Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotypePLOS Neglected Tropical Diseases 2018Vaccine Expi293
                                  Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-IgEBioMedicine 2018Vaccine Expi293
                                  Neuraminidase Inhibition Contributes to Influenza A Virus Neutralization by Anti-Hemagglutinin Stem AntibodiesJournal of Experimental Medicine 2019Vaccine Expi293
                                  Zika virus-like particle (VLP) based vaccinePLOS Neglected Tropical Diseases 2017Vaccine Expi293
                                  Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization ActivityJournal of Pharmaceutical Sciences2019Vaccine ExpiCHO
                                  Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig GeneCell Host & Microbe 2018Vaccine ExpiCHO
                                  Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomicseLife Science2019Vaccine Expi293 and ExpiCHO
                                  Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitroAntiviral Research2020COVIDExpiCHO
                                  Development of an inactivated vaccine candidate for SARS-CoV-2Science2020COVIDExpi293
                                  Optimization of Surface Display of DENV2 E Protein on a Nanoparticle to Induce Virus Specific Neutralizing Antibody ResponsesBioconjugate Chemistry2018Vaccine Expi293
                                  Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccinesScience Advances 2020Vaccine ExpiCHO
                                  Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational IncompatibilityCell Host & Microbe 2019Vaccine ExpiCHO
                                  Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBAActa Crystallographica Section F Structural Biology Communications2017Vaccine Expi293
                                  SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test SetupCurrent Protocols in Microbiology2020COVIDExpi293
                                  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience2020COVIDExpi293
                                  A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoVScience2020COVIDExpi293 and ExpiCHO
                                  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenPNAS2017COVIDExpi293
                                  Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid AntibodiesCell2020COVIDExpiCHO
                                  Cryo-EM structure of full-length HIV-1 Env bound with the Fab of antibody PG16Journal of Molecular Biology2020COVIDExpi293
                                  Structure-based design of prefusion-stabilized SARS-CoV-2 spikesScience2020COVIDExpiCHO
                                  Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spikeNature 2020COVIDExpi293

                                  Expi Expression Systems

                                  Application notes

                                  Protocol Calculator

                                  Literature

                                  Protocol guide

                                  Scientific posters

                                  Additional resources

                                  Gibco Protein Expression Basics videos

                                  How to set up your lab for mammalian transient protein expression
                                  This video provides a quick overview on how to set up your lab for mammalian transient protein expression.
                                  Video Player is loading.
                                  Current Time 0:00
                                  Duration 3:20
                                  Loaded: 4.95%
                                  Stream Type LIVE
                                  Remaining Time 3:20
                                   
                                  1x
                                    • Chapters
                                    • descriptions off, selected
                                    • captions off, selected
                                    • en (Main), selected
                                      1. Now Playing
                                        Up NextHow to set up your lab for mammalian transient protein expression

                                        This video provides a quick overview on how to set up your lab for mammalian transient protein expression.

                                      2. Now Playing
                                        Up NextExpiCHO: Transient CHO Expression Protocol

                                        Learn how to produce recombinant proteins with the Gibco™ ExpiCHO™ Expression System and achieve 3 g/L protein yields in a transient CHO system.

                                      3. Now Playing
                                        Up NextExpi293: Transient HEK 293 Expression Protocol

                                        Learn how to produce recombinant proteins with the Gibco™ Expi293™ Expression System and achieve gram per liter protein yields in a transient HEK 293 system.

                                    For Research Use Only. Not for use in diagnostic procedures.